Home » Topics » Endocrine/metabolic, BioWorld Science

Endocrine/metabolic, BioWorld Science
RSS

RF-1051 cleared to enter phase II

April 19, 1996

Obesity gene identified

April 19, 1996

Warner-Lambert reports NPY1 antagonist

April 19, 1996

Warner-Lambert, Pfizer intend to copromote atorvastatin

April 19, 1996

FDA approves new indication for Pravachol

April 19, 1996

ACAT inhibitor reported by Nisshin Flour Milling

April 19, 1996

Human Genome Sciences' research into cathepsin K

April 19, 1996

Fujisawa describes cathepsin L/B inhibitor of fungal origin

April 19, 1996

Cortecs' oral salmon calcitonin shows favorable phase II results

April 19, 1996

Vivus files NDA for Muse

April 12, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 22, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 22, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
ABS-1230 controls seizures in KCNT1-driven severe epilepsy
BioWorld Science
Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...